Background

Professor Paul Dietze is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. He is an NHMRC Senior Research Fellow and a past ARC Future Fellow and VicHealth Public Health Research Fellow. With more than 20 years’ experience and an outstanding track record, his work has established internationally innovative surveillance systems and applied research designs that break new ground in the public health research into alcohol and other drug use and related harms in Australia.

He has produced more than 160 journal articles along with many other reports of significant impact that have changed practice in the area of alcohol and other drugs in this country. During the course of his research career he has received more than $20 million of research funding.

These grants provided funds to conduct or establish:

• an NHMRC Centre for Research Excellence into Injecting Drug Use
• a large cohort of people who inject drugs, allowing not only for trajectory analyses of drug using careers, but also service and intervention evaluation
• the first-ever case-crossover study of the risk factors for non-fatal heroin overdose
• a comprehensive system for monitoring non-fatal heroin overdose across the mainland states
• the first-ever study of the nature and extent of medication overdose across an Australian city
• the first randomised trial of intranasal naloxone for the reversal of heroin overdose
• the first study of the relationship between income inequality and alcohol-related harm in Australia
• multi-level modelling of the relationships between alcohol outlets and young people’s drinking
• the first study of risky drinking amongst a large sample of elite athletes in the world.

Paul’s work has had major impact. Naloxone is now administered via the intranasal route in many parts of the USA as a result of his work in Victoria. He was a member of the ‘Guidelines Development Group on the management of opioid overdose’ for the World Health Organization, which met in Geneva in February 2014 with the guidelines released in late 2014.

He has been involved in the development and implementation of a variety of heroin overdose prevention initiatives including the Direct Response to Overdose (DROP) project and he is leading the evaluation of the first Australian bystander naloxone program being implemented in the ACT. He was a key member of the Expanding Naloxone Availability in the ACT Committee. He is a Chief Investigator on a trial of intranasal naloxone in the Sydney Medically Supervised Injecting Centre that commenced in January 2012.

He co-convenes the Victorian Injecting Drug Harm Reduction Network with Penington Institute through which research findings on injecting drug use are disseminated to the alcohol and drug sector.

He has received numerous awards and prizes in recognition of his work.

Most significant publications:

• Dietze P, Horyniak D, Agius P, Munir V, Smit de V, Johnston J, et al. Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission. Acad Emerg Med. 2014;21(11):1226-31.
• Dietze P, Jenkinson R, Aitken C, Stoove M, Jolley D, Hickman M, et al. The relationship between alcohol use and injecting drug use: impacts on health and social functioning. Drug Alcohol Depend. 2013;128(1-2):111-15.
• Dietze P, Stoove M, Miller P, Kinner S, Bruno R, Alati R, et al. The self-reported personal well-being of a sample of Australian injecting drug users. Addiction. 2010;105(12):2141-8.
• Truong A, Jamieson L, Higgs P, Cogger S, Burns L, Dietze P. Oral Health-Related Quality of Life among an Australian sample of people who inject drugs. Journal Public Health Dent. in press - accepted 26/1/15.
• Strang J, Bird SM, Dietze P, Gerra G, McLellan AT. Take-home emergency naloxone to prevent deaths from heroin overdose. BMJ. 2014;349:g6580. Epub 2014/11/08.
• Dietze PM, Livingston M, Callinan S, Room R. The big night out: what happens on the most recent heavy drinking occasion among young Victorian risky drinkers? Drug Alcohol Rev. 2014;33(4):346-53.
• McCormack A, Aitken C, Cogger S, Burns L, Dietze P. Syringe stockpiling by people who inject drugs: an evaluation of current measures for needle and syringe program coverage. Am J Epidemiol. in press.

Appointments

• 2017: Program Director, Behaviours and Health Risks, Burnet Institute
• Deputy Head, Centre for Population Health, Burnet Institute

Positions

• 2005-2007: Program Leader, Epidemiology and Surveillance, Turning Point Alcohol and Drug Centre
• 2001-2004: Senior Research Fellow, School of Health and Social Development, Deakin University, Victoria, Australia

Qualifications

• 1995: PhD, Monash University, Victoria, Australia
• 1989: BSc (Hons), Monash University, Australia

Awards

• 2013: Burnet Institute Fenner Award
• 2010: Burnet Institute Gust-McKenzie Medal
• 2006-2010: National Health & Medical Research Council Career Development Award
• 2001-2006: VicHealth Public Health Research Fellowship
• 2004: Premier’s Drug Prevention Council Travelling Scholarship
• 1999: Victoria Fellowship
• 1992-1993: Monash Graduate Scholarship
• 1991: Lionel Murphy Postgraduate Scholarship

Projects (29)

Current (16)

• 

  Attitudes to drug use among East African migrants in Melbourne’s western suburbs

• 

  CREIDU: Centre for Research Excellence into Injecting Drug Use

• 

  EC Partnership: Eliminate Hepatitis C Partnership

• 

  EDRS: Ecstasy and related Drugs Reporting System

• 

  Evaluation of the Multicultural Drug and Alcohol Service

• 

  Examining interventions targeting high-risk drinking among young Australians

• 

  Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

• 

  IDRS: Illicit Drug Reporting System

• 

  Needle and Syringe Program (NSP) Snapshot Study

• 

  Project Geldom

• 

  SimDrink: Using simulation modelling to perform alcohol policy experiments

• 

  SuperMIX: The Melbourne Injecting Drug User Cohort Study

• 

  The B-VAX Project: Hep B vaccinations for people who inject drugs

• 

  The elimination of hepatitis C as a global public health threat

• 

  The oral health of people who inject drugs (PWID)

• 

  The QuickStart Study

Past (4)

• 

  PATH Cohort Study

• 

  Smartphone apps for alcohol health promotion

• 

  The Drug Policy Modelling Program (DPMP)

• 

  Victorian Pharmaceutical Opioid Monitoring Project

Publications (273)

2021 (12)

• Trends in cocaine use, markets and harms in Australia, 2003-2019.
  Man N, Chrzanowska A, Price O, Bruno R, Dietze PM, Sisson SA, Degenhardt L, Salom C, Morris L, Farrell M, Peacock A
  Drug Alcohol Rev. 2021 Feb; Epub ahead of print
• Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
  Roxburgh A, Jauncey M, Day C, Bartlett M, Cogger S, Dietze P, Nielsen S, Latimer J, Clark N
  Harm Reduct J. 2021 Feb; 18(1):20
• Coding and classification of heroin overdose calls by MPDS dispatch software: Implications for bystander response with naloxone.
  Dietze P, Crossin R, Scott D, Smith K, Wilson J, Burgess S, Lubman DI, Cantwell K
  Resuscitation. 2021 Feb; 159:13-18
• Integrating episodes of imprisonment and the cascade of care for opioid use disorder.
  Cossar R, Stewart A, Winter R, Curtis M, Dietze P, Ogloff JRP, Stoové M
  Addiction. 2021 Feb; 116(2):427-428
• Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial.
  McKetin R, Quinn B, Higgs P, Berk M, Dean OM, Turner A, Kelly PJ, Lubman DI, Carter G, Baker AL, Manning V, Thomas T, Bathish R, Raftery D, Saunders L, Wrobel A, Meehan A, Sinclair B, Reid D, Arunogiri S, Hill H, Cordaro F, Dietze PMWrobel, Alcyone Meehan, Barbara Sinclair, David Reid, Shalini Arunogiri, Harry Hill, Frank Cordaro, Paul M Dietze
  Drug Alcohol Rev. 2021 Jan; Epub ahead of print
• Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities.
  Nielsen S, Sanfilippo P, Belackova V, Day C, Silins E, Lintzeris N, Bruno R, Grebely J, Lancaster K, Ali R, Bell J, Dietze P, Degenhardt L, Farrell M, Larance B
  Addiction. 2021 Jan; Epub ahead of print
• Prevalence and correlates of simultaneous, multiple substance injection (co-injection) amongst people who inject drugs in Melbourne, Australia.
  Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P
  Addiction. 2021 Jan; Epub ahead of print
• A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence.
  Quinn B, Ward B, Agius PA, Jenkinson R, Hickman M, Sutton K, Hall C, McKetin R, Farrell M, Cossar R, Dietze PM
  Drug Alcohol Rev. 2021 Jan; Epub ahead of print
• Trends in adolescent drinking across 39 high-income countries: exploring the timing and magnitude of decline.
  Vashishtha R, Pennay A, Dietze P, Marzan MB, Room R, Livingston M
  Eur J Public Health. 2021 Jan; Epub ahead of print
• Parent and child co-resident status among an Australian community-based sample of methamphetamine smokers.
  Ward B, Kippen R, Reupert A, Maybery D, Agius PA, Quinn B, Jenkinson R, Hickman M, Sutton K, Goldsmith R, Dietze PM
  Drug Alcohol Rev. 2021 Jan; Epub ahead of print
• Workplace intervention programmes for decreasing alcohol use in military personnel: a systematic review.
  Watterson JR, Gabbe B, Rosenfeld JV, Ball H, Romero L, Dietze P
  BMJ Mil Health. 2021 Jan; Epub ahead of print
• Exploring the Impact of Secondary Supply Laws on Adolescent Drinking Trends in Australia.
  Vashishtha R, Pennay A, Dietze P, Livingston M
  J Stud Alcohol Drugs. 2021 Jan; 82(1):76-83

2020 (25)

• Adequate Analgesia and Oral Care Attendance in Opiate Dependent Individuals.
  Abdelsalam S, Van Den Boom W, Dietze P, Erbas B, Higgs P
  J Dent Res. 2020 Dec; 99(12):1406
• Striving for hepatitis C elimination - the role of a vaccine.
  Hellard M, Drummer H, Scott N
  Clin Infect Dis. 2020 Dec; 77(11):2991-2992
• Patient-specific record linkage between emergency department and hospital admission data for a cohort of people who inject drugs: methodological considerations for frequent presenters.
  Di Rico R, Nambiar D, Gabbe B, Stoové M, Dietze P
  BMC Med Res Methodol. 2020 Nov; 20(1):283
• Population patterns in Alcohol Use Disorders Identification Test (AUDIT) scores in the Australian population; 2007-2016.
  O'Brien H, Callinan S, Livingston M, Doyle JS, Dietze PM
  Aust N Z J Public Health. 2020 Oct; 44(6):462-467
• Review article: Rapid review of the emergency department-initiated buprenorphine for opioid use disorder.
  Salter H, Hutton J, Cantwell K, Dietze P, Higgs P, Straub A, Zordan R, Lloyd-Jones M
  Emerg Med Australas. 2020 Oct; 32(6):924-934
• Managing opioid overdose in pregnancy with nasal naloxone.
  Bonomo Y, Pastor A, Leung L, Blandthorn J, Dietze P
  Aust N Z J Obstet Gynaecol. 2020 Oct; 60(5):E11-E12
• Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia.
  Colledge S, Larney S, Bruno R, Gibbs D, Degenhardt L, Yuen WS, Dietze P, Peacock A
  Drug Alcohol Depend. 2020 Aug; 216:108267
• Effects of Question Type and Order When Measuring Peak Consumption of Risky Drinking Events.
  Yeung JT, Livingston M, Callinan S, Wright C, Kuntsche E, Room R, Dietze P
  Alcohol Alcohol. 2020 Aug; 55(6):631-640
• The impact of Victoria's real time prescription monitoring system (SafeScript) on a cohort of people who inject drugs.
  Fetene DM, Higgs P, Nielsen S, Djordjevic F, Dietze P
  Med J Aust. 2020 Jun; 213(3):141
• Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia.
  Sutherland R, Dietze PM, Gisev N, Bruno R, Campbell G, Memedovic S, Peacock A
  Drug Alcohol Rev. 2020 Jun; 39(5):568-574
• Illicit drug use and harms in Australia in the context of COVID-19 and associated restrictions: Anticipated consequences and initial responses.
  Dietze PM, Peacock A
  Drug Alcohol Rev. 2020 May; 39(4):297-300
• Effectiveness of an Ecological Momentary Intervention for Reducing Risky Alcohol Consumption Among Young Adults: Protocol for a Three-Arm Randomized Controlled Trial.
  Wright C, Dietze PM, Kuntsche E, Livingston M, Agius PA, Room R, Raggatt M, Hellard M, Lim MSC
  JMIR Res Protoc. 2020 Mar; 9(3):e14190
• Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018.
  Tse WC, Sanfilippo P, Lam T, Dietze P, Nielsen S
  Med J Aust. 2020 Mar; 212(7):314-320
• Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.
  Palmer A, Scott N, Dietze P, Higgs P
  Harm Reduct J. 2020 Feb; 17(1):14
• A digital pornography literacy resource co-designed with vulnerable young people: Development of "The Gist"
  Davis AC, Wright CC, Murphy S, Dietze P, Temple-Smith MJ, Hellard ME, Lim MS
  J Med Internet Res. 2020 Feb; 22(6):e15964
• Blood donation amongst people who inject drugs in Australia: research supporting policy change.
  Quinn B, Pearson R, Cutts J, Seed C, Scott N, Hoad V, Dietze P, Wilson D, Maher L, Thompson A, Farrell M, Harrod M, Caris S, Pink J, Kotsiou G, Hellard M
  Vox Sang. 2020 Feb; 115(3):162-70
• Social domains of discrimination against people who inject drugs: Links with health and wellbeing.
  Couto E Cruz C, Salom C, Parsell C, Dietze P, Burns L, Alati R
  Int J Drug Policy. 2020 Jan; 77:102620
• Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
  Lintzeris N, Monds LA, Bravo M, Read P, Harrod ME, Gilliver R, Wood W, Nielsen S, Dietze PM, Lenton S, Shanahan M, Jauncey M, Jefferies M, Hazelwood S, Dunlop AJ, Greenaway M, Haber P, Ezard N, Malcom A
  Drug Alcohol Rev. 2020 Jan; 39(1):55-65
• Response to Kwon et al. "Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016".
  O'Keefe D, Aitken C, Dietze P
  Drug Alcohol Depend. 2020 Jan; 207:107800
• Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.
  Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; InC3 Collaborative.
  Clin Infect Dis. 2020 Jan; 70(1):123-131
• Commentary on Arunogiri et al. (2019): Findings from surveillance of patterns of drug use and related harms need careful interpretation, promotion and response.
  Dietze P, Horyniak D
  Addiction. 2020 Jan; 115(3):480-481
• "They just don't care about us!": Police custody experiences for young men with histories of injecting drug use
  Walker S, Higgs P, Stoové M, Wilson M
  Aust NZ J Criminol. 2020 Jan; 53(1):102-120
• Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia.
  Larance B, Degenhardt L, Grebely J, Nielsen S, Bruno R, Dietze P, Lancaster K, Larney S, Santo T Jr, Shanahan M, Memedovic S, Ali R, Farrell M
  Addiction. 2020 Jan; 115(7):1295-1305
• Conflict and communication: managing the multiple affordances of take-home naloxone administration events in Australia.
  Farrugia A, Neale J, Dwyer R, Fomiatti R, Fraser S, Strang J, Dietze P
  Addict Res Theory. 2020 Jan; 28(1):29-37
• Harm reduction programs and policy in Australia: barriers and enablers to effective implementation.
  O’Keefe D, Ritter A, Stoové M, Hughes C, Dietze P
  SUCHT. 2020 Jan; 66(1):33-43

2019 (17)

• Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.
  Dietze P, Jauncey M, Salmon A, Mohebbi M, Latimer J, van Beek I, McGrath C, Kerr D
  JAMA Netw Open. 2019 Nov; 2(11):e1914977
• Testing Consensus About Situational Norms on Drinking: A Cross-National Comparison.
  Room R, Kuntsche S, Dietze P, Munné M, Monteiro M, Greenfield TK
  J Stud Alcohol Drugs. 2019 Nov; 80(6):651-659
• Comparing short versions of the Alcohol Use Disorders Identification Test (AUDIT) in a military cohort.
  Watterson J, Gabbe B, Dietze P, Bowring A, Rosenfeld JV
  J R Army Med Corps. 2019 Oct; 165(5):312-316
• Measures of harm reduction service provision for people who inject drugs.
  O'Keefe D, Bluthenthal RN, Kral AH, Aitken CK, McCormack A, Dietze PM
  Bull World Health Organ. 2019 Sep; 97(9):605-611
• Correlates of Reduced Alcohol Consumption among a Sample of Young Australians.
  Raggatt M, Wright C, Dietze P, Pennay A, Caluzzi G, Lim M
  Alcohol Alcohol. 2019 Sep; 54(5):525-531
• Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
  Nielsen S, Kowalski M, Wood P, Larney S, Bruno R, Shanahan M, Lenton S, Dietze P, Green T, Murnion B, Ritter A
  Res Social Adm Pharm. 2019 Aug; 15(8):1047-1055
• The contexts of heavy drinking: A systematic review of the combinations of context-related factors associated with heavy drinking occasions.
  Stanesby O, Labhart F, Dietze P, Wright CJC, Kuntsche E
  PLoS One. 2019 Jul; 14(7):e0218465
• A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
  McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Baker AL, Sinclair B, Reid D, Manning V, Te Pas N, Liang W, Thomas T, Bathish R, Kent M, Raftery D, Arunogiri S, Cordaro F, Hill H, Berk M
  Trials. 2019 Jun; 20(1):325
• The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
  Kirwan A, Curtis M, Dietze P, Aitken C, Woods E, Walker S, Kinner S, Ogloff J, Butler T, Stoové M
  J Urban Health. 2019 Apr; 96(3):400-410
• Five-year Changes in Methamphetamine Use, Dependence, and Remission in a Community-recruited Cohort.
  Lanyon C, Nambiar D, Higgs P, Dietze P, Quinn B
  J Addict Med. 2019 Apr; 13(2):159-165
• The association between experiencing discrimination and physical and mental health among PWID.
  Couto E Cruz C, Salom CL, Dietze P, Burns L, Alati R
  Int J Drug Policy. 2019 Mar; 65:24-30
• What can Australia learn from the North American opioid crisis? The role of opioid regulation and other evidence-based responses.
  Nielsen S, Dietze PM
  Drug Alcohol Rev. 2019 Mar; 38(3):223-225
• Take-home naloxone and the politics of care.
  Farrugia A, Fraser S, Dwyer R, Fomiatti R, Neale J, Dietze P, Strang J
  Sociol Health Illn. 2019 Feb; 41(2):427-443
• Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.
  Crossin R, Scott D, Arunogiri S, Smith K, Dietze PM, Lubman DI
  Med J Aust. 2019 Feb; 210(2):75-79
• Barriers and opportunities in the translation of mobile phone and social media interventions between research and health promotion practice in Australia: a qualitative study of expert perspectives.
  Wright CJC, Schwarzman J, Dietze PM, Crockett B, Lim MSC
  Health Res Policy Syst. 2019 Jan; 17(1):5
• Patterns in Reduction or Cessation of Drinking in Australia (2001-2013) and Motivation for Change.
  Pennay A, Callinan S, Livingston M, Lubman DI, Holmes J, MacLean S, Herring R, Dietze P
  Alcohol Alcohol. 2019 Jan; 54(1):79-86
• Injection drug network characteristics as a predictor of injection behaviour.
  Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M
  Epidemiol Infect. 2019 Jan; 147:e173

2018 (30)

• Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
  O'Keefe D, Wilkinson A, Aitken C, Dietze P
  PLoS One. 2018 Dec; 13(12):e0209280
• Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs.
  Di Rico R, Nambiar D, Stoové M, Dietze P
  BMC Health Serv Res. 2018 Dec; 18(1):945
• Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
  Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P
  Lancet Infect Dis. 2018 Oct; 18(12):1397-1409
• Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use.
  Stewart AC, Cossar R, Dietze P, Armstrong G, Curtis M, Kinner SA, Ogloff JRP, Kirwan A, Stoové M
  Health Justice. 2018 Oct; 6(1):19
• Blood-borne virus transmission in an urban, culturally diverse neighbourhood: results from a cross-sectional bio-behavioural survey using innovative outreach methods in a hard-to-reach population.
  Peach E, Cogger S, Byron K, Francis P, O'Keefe D, Higgs P, Stoove M, Elmore K, Dietze P, Hellard M
  Sex Health. 2018 Oct; 15(1):54-60
• Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
  Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M
  Harm Reduct J. 2018 Sep; 15(1):48
• Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
  O'Keefe D, Aitken C, Scott N, Dietze P
  Drug Alcohol Depend. 2018 Aug; 191:259-265
• Should sterile needle and syringe wastage be included within individual-level needle and syringe coverage measures?
  O'Keefe D, Aitken C, Dietze P
  Int J Drug Policy. 2018 Aug; 60:8-9
• Mobile Phone-Based Ecological Momentary Intervention to Reduce Young Adults' Alcohol Use in the Event: A Three-Armed Randomized Controlled Trial.
  Wright C, Dietze PM, Agius PA, Kuntsche E, Livingston M, Black OC, Room R, Hellard M, Lim MS
  JMIR Mhealth Uhealth. 2018 Jul; 6(7):e149
• Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing.
  Couto E Cruz C, Salom CL, Dietze P, Lenton S, Burns L, Alati R
  Drug Alcohol Depend. 2018 Jul; 190:188-194
• Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas.
  Hainsworth SW, Dietze PM, Wilson DP, Sutton B, Hellard ME, Scott N
  PLoS One. 2018 Jun; 13(6):e0198336
• Repeat participation in annual cross-sectional surveys of drug users and its implications for analysis.
  Agius PA, Aitken CK, Breen C, Dietze PM
  BMC Res Notes. 2018 Jun; 11(1):349
• Are there differences in individual-level needle and syringe coverage across Australian jurisdictions related to program policy? A preliminary analysis.
  Hill P, O'Keefe D, Dietze PM
  Drug Alcohol Rev. 2018 May; 37(5): 653-657
• Is there gender convergence in risky drinking when taking birth cohorts into account? Evidence from an Australian national survey 2001-2013.
  Livingston M, Callinan S, Dietze P, Stanesby O, Kuntsche E
  Addiction. 2018 May; 113(11):2019-2028
• Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
  O'Keefe D, Aung SM, Pasricha N, Wun T, Linn SK, Lin N, Aitken C, Hughes C, Dietze P
  Int J Drug Policy. 2018 May; 58:22-30
• Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.
  Dietze PM, Stare M, Cogger S, Nambiar D, Olsen A, Burns L, Lenton S
  Drug Alcohol Rev. 2018 May; 37(4):457-463
• Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs?
  Olsen A, McDonald D, Lenton S, Dietze PM
  Drug Alcohol Rev. 2018 May; 37(4):499-501
• Implications of survey labels and categorisations for understanding drug use in the context of sex among gay and bisexual men in Melbourne, Australia.
  Ryan KE, Wilkinson AL, Pedrana A, Quinn B, Dietze P, Hellard M, Stoové M
  Int J Drug Policy. 2018 May; 55:183-186
• Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.
  Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P; TAP study group.
  BMC Infect Dis. 2018 Apr; 18(1):151
• The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons.
  Jauncey M, Livingston M, Salmon AM, Dietze P.
  Int J Drug Policy. 2018 Mar; 53:17-22
• Are people who inject drugs frequent users of emergency department services? A cohort study (2008-2013).
  Nambiar D, Spelman T, Stoové M, Dietze P
  Subst Use Misuse. 2018 Feb; 53(3):457-465
• Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.
  Dietze PM, Draper B, Olsen A, Chronister KJ, van Beek I, Lintzeris N, Dwyer R, Nelson M, Lenton S
  Drug Alcohol Rev. 2018 Feb; 37(4):472-479
• The association between intentional overdose and same-sex sexual intercourse in a cohort of people who inject drugs in Melbourne, Australia.
  O'Keefe D, Bowring A, Aitken C, Dietze P
  Subst Use Misuse. 2018 Feb; 53(5):755-762
• The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia.
  Cossar R, Stoové M, Kinner SA, Dietze P, Aitken C, Curtis M, Kirwan A, Ogloff JRP
  Health Justice. 2018 Jan; 6(1):1
• The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.
  Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative.
  Clin Infect Dis. 2018 Jan; 66(1):20-28
• How much alcohol is consumed outside of the lifetime risk guidelines in Australia?
  Callinan S, Livingston M, Room R, Dietze PM
  Drug Alcohol Rev. 2018 Jan; 37(1):42-47
• Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
  Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze P, Lenton S, Kearley J, van Beek I
  Drug Alcohol Rev. 2018 Jan; 37(4):464-471
• Alcohol consumption trends in Australia: Comparing surveys and sales-based measures.
  Livingston M, Callinan S, Raninen J, Pennay A, Dietze PM
  Drug Alcohol Rev. 2018 Jan; 37(Suppl 1):S9-S14
• Managing opioid overdose in pregnancy with take-home naloxone.
  Blandthorn J, Bowman E, Leung L, Bonomo Y, Dietze P
  Aust N Z J Obstet Gynaecol. 2018 Jan; 58(4):460-462
• Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.
  O'Keefe D, Scott N, Aitken C, Dietze P
  J Public Health. 2018 Jan; 40(3):e336-e342

2017 (23)

• The attribution of a death to heroin: A model to help improve the consistent and transparent classification and reporting of heroin-related deaths.
  Stam NC, Gerostamoulos D, Dietze PM, Parsons S, Smith K, Lloyd B, Pilgrim JL
  Forensic Sci Int. 2017 Oct; 281:18-28
• Injecting drug use continues in older users too.
  Higgs P, Dietze P
  BMJ. 2017 Oct; 359:j4738
• A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.
  Nambiar D, Stoové M, Hickman M, Dietze P
  BMJ Open. 2017 Aug; 7(8):e014854
• Alcohol and other substance use among a sample of young people in the Solomon Islands.
  Quinn B, Peach E, Wright CJC, Lim MSC, Davidson L, Dietze P
  Aust N Z J Public Health. 2017 Aug; 41(4):358-364
• New hepatitis C antiviral treatments eliminate the virus.
  Doyle JS, Thompson AJ, Higgs P, Stoove M, Dietze PM, Hellard ME
  Lancet. 2017 Jul; 390(10092):358-359
• "Just not all ice users do that": investigating perceptions and potential harms of Australia's Ice Destroys Lives campaign in two studies.
  Douglass CH, Early EC, Wright CJC, Palmer A, Higgs P, Quinn B, Dietze PM, Lim MSC
  Harm Reduct J. 2017 Jul; 14(1):45
• Gearing up at the Review.
  Room R, Dietze P, McKetin R
  Drug Alcohol Rev. 2017 Jul; 36(4):441
• Beyond basic feedback in mobile brief interventions: Designing SMS message content for delivery to young adults during risky drinking events.
  Wright CJC, Dietze PM, Lim MSC
  JMIR mHealth uHealth. 2017 Jun; 5(6):e79
• Injecting drug use in low and middle income countries: opportunities to improve care and prevent harm.
  O'Keefe D, Stoové M, Doyle J, Dietze P, Hellard M.
  J Viral Hepat. 2017 Jun; 24(9):714-724
• Using simulation modelling to examine the impact of venue lockout and last-drink policies on drinking-related harms and costs to licensees.
  Scott N, Livingston M, Reporter I, Dietze P
  Aust N Z J Public Health. 2017 Jun; 41(3):243-247
• Longitudinal changes in personal wellbeing in a cohort of people who inject drugs.
  Scott N, Carrotte ER, Higgs P, Stoové MA, Aitken CK, Dietze PM
  PLoS One. 2017 May; 12(5):e0178474
• How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
  O'Keefe D, McCormack A, Cogger S, Aitken C, Burns L, Bruno R, Stafford J, Butler K, Breen C, Dietze P
  Int J Drug Policy. 2017 May; 46:96-106
• An ecological momentary intervention to reduce alcohol consumption in young adults delivered during drinking events: Protocol for a pilot randomized controlled trial.
  Wright CJ, Dietze PM, Agius PA, Kuntsche E, Room R, Livingston M, Hellard M, Lim MS
  JIMR Research Protocols. 2017 May; 6(5):e95
• New psychoactive substances: Purchasing and supply patterns in Australia.
  Sutherland R, Bruno R, Peacock A, Dietze P, Breen C, Burns L, Barratt MJ
  Hum Psychopharmacol. 2017 May; 32(3):e2577
• Trends in reports of driving following illicit drug consumption among regular drug users in Australia, 2007-2013: Has random roadside drug testing had a deterrent effect?
  Horyniak D, Dietze P, Lenton S, Alati R, Bruno R, Matthews A, Breen C, Burns L
  Accid Anal Prev. 2017 May; 104:146-155
• Frequent emergency department presentations among people who inject drugs: A record linkage study.
  Nambiar D, Stoové M, Dietze P
  Int J Drug Policy. 2017 May; 44:115-120
• Differences in emergency ambulance demand between older adults living in residential aged care facilities and those living in the community in Melbourne, Australia.
  Cantwell K, Morgans A, Smith K, Livingston M, Dietze P
  Australas J Ageing. 2017 May; 36(3):212-221
• Measuring the effectiveness of in-hospital and on-base Prevent Alcohol and Risk-related Trauma in Youth (P.A.R.T.Y.) programs on reducing alcohol related harms in naval trainees: P.A.R.T.Y. Defence study protocol.
  Watterson J, Gabbe B, Dietze P, Thompson J, Oborn M, Rosenfeld JV
  BMC Public Health. 2017 May; 17(1):380
• Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
  O'Keefe D, Scott N, Aitken C, Dietze P
  Drug Alcohol Depend. 2017 Apr; 176:7-13
• Correlates of alcohol consumption on heavy drinking occasions of young risky drinkers: event versus personal characteristics.
  Dietze P, Agius PA, Livingston M, Callinan S, Jenkinson R, Lim MS, Wright CJ, Room R
  Addiction. 2017 Mar; 112(8): 1369-1377
• The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
  Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM
  Epidemiol Infect. 2017 Mar; 145(4):796-801
• The role of respect in interactions with police among substance-using African refugee young people in Melbourne, Australia
  Horyniak D, Higgs P, Cogger S, Dietze P
  J Ethn Crim Just. 2017 Feb; 15(2):185-204
• Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
  Sutherland R, Bruno R, Peacock A, Lenton S, Matthews A, Salom C, Dietze P, Butler K, Burns L, Barratt MJ
  Int J Drug Policy. 2017 Feb; 43:23-32

2016 (30)

• Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.
  Dietze PM, Quinn B, Hughes C
  Med J Aust. 2016 Nov; 205(9):425-426
• Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providers
  Dwyer R, Fraser S, Dietze P
  Drugs Edu Prev Policy. 2016 Oct; 23(5):388-396
• Who 'likes' alcohol? Young Australians' engagement with alcohol marketing via social media and related alcohol consumption patterns.
  Carrotte ER, Dietze PM, Wright CJ, Lim MS
  Aust N Z J Public Health. 2016 Sep; 40(5):474-479
• Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.
  Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM
  Drug and Alcohol Dependence. 2016 Aug; 168:140-146
• Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.
  O'Keefe D, Scott N, Aitken C, Dietze P
  BMC Health Serv Res. 2016 Aug; 16(1):411
• Field engagement further facilitates hepatitis B vaccination completion: Letter in response to: Day et al. (in press).
  Higgs P, Doyle J, Luppi J, Dietze P, Hellard M
  J Clin Virol. 2016 Jul; 82:64-65
• Drinking Contexts and Alcohol Consumption: How Much Alcohol Is Consumed in Different Australian Locations?
  Callinan S, Livingston M, Room R, Dietze P
  J Stud Alcohol Drugs. 2016 Jul; 77(4):612-619
• Understanding trends in Australian alcohol consumption-an age-period-cohort model.
  Livingston M, Raninen J, Slade T, Swift W, Lloyd B, Dietze P
  Addiction. 2016 Jun; 111(9):1590-1598
• The introduction of CCTV and associated changes in heroin purchase and injection settings in Footscray, Victoria, Australia.
  Scott N, Higgs P, Caulkins JP, Aitken C, Cogger S, Dietze P
  J Exp Criminol. 2016 Apr; 12(2):265-275
• An investigation of strategies used in alcohol brand marketing and alcohol-related health promotion on Facebook.
  Lim MS, Hare JD, Carrotte ER, Dietze PM
  Digital Health. 2016 Apr; 2:1-7
• Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
  McCormack AR, Aitken CK, Burns LA, Cogger S, Dietze PM
  Am J Epidemiol. 2016 Apr; 183(9):852-860
• Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
  Dietze, P, Cantwell K
  Addiction. 2016 Apr; 111(4):584-586
• TreatMethHarm: An agent-based simulation of how people who use methamphetamine access treatment.
  Lamy F, Quinn B, Dwyer R, Thomson N, Moore D, Dietze P
  The Journal of Artificial Societies and Social Simulation. 2016 Mar; 19(2):3
• National survey data can be used to measure trends in population alcohol consumption in Australia.
  Livingston M, Dietze P
  Aust N Z J Public Health. 2016 Mar; 40(3):233-235
• How is methamphetamine typically purchased and used in Melbourne, Australia? Reports from a cohort of people who inject drugs.
  Scott N, Caulkins JP, Dietze P
  Addiction Research and Theory. 2016 Mar; 24(5):416-425
• Australia reschedules naloxone for opioid overdose.
  Lenton SR, Dietze PM, Jauncey M
  Med J Aust. 2016 Mar; 204(4):146-147
• Take-home naloxone programs and calls to emergency services.
  Kirwan A, Curtis M, van Beek IA, Cantwell K, Dietze PM
  Med J Aust. 2016 Mar; 204(4):143
• Heavy alcohol consumption among marginalised African refugee young people in Melbourne, Australia: motivations for drinking, experiences of alcohol-related problems and strategies for managing drinking.
  Horyniak D, Higgs P, Cogger S, Dietze P, Bofu T
  Ethn Health. 2016 Mar; 21(3):284-299
• The effects of extended public transport operating hours and venue lockout policies on drinking-related harms in Melbourne, Australia: Results from SimDrink, an agent-based simulation model.
  Scott N, Hart A, Wilson J, Livingston M, Moore D, Dietze P
  Int J Drug Policy. 2016 Feb; 32:44-49
• Participatory development of MIDY (Mobile Intervention for Drinking in Young people).
  Wright CJ, Dietze PM, Crockett B, Lim MS
  BMC Public Health. 2016 Feb; 16(1):184
• Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
  Betts KS, Chan G, McIlwraith F, Dietze P, Whittaker E, Burns L, Alati R
  Addiction. 2016 Feb; 111(7):1214-1223
• Public injecting and public amenity in an inner-city suburb of Melbourne, Australia.
  Dwyer R, Power R, Denham G, Dietze P
  J Subst Use. 2016 Feb; 21(2):162-169
• SimDrink: An agent-based NetLogo model of young, heavy drinkers for conducting alcohol policy experiments.
  Scott N, Livingston M, Hart A, Wilson J, Moore D, Dietze P
  JASS. 2016 Jan; 19(1):10
• 'A Drink That Makes You Feel Happier, Relaxed and Loving': Young People's Perceptions of Alcohol Advertising on Facebook.
  Weaver ER, Wright CJ, Dietze PM, Lim MS
  Alcohol Alcohol. 2016 Jan; 51(4):481-486
• It stops with us: Peer responses increase availability of sterile injecting equipment.
  Higgs P, Cogger S, Kelsall J, Gavin N, Elmore K, Francis P, Dietze P
  Int J Drug Policy. 2016 Jan; 29:96-97
• Temporal trends in falls cases seen by EMS in Melbourne: The effect of residence on time of day and day of week patterns
  Cantwell K, Burgess S, Morgans A, Smith K, Livingston M, Dietze P
  Injury. 2016 Jan; 47(1):266-271
• From initiating injecting drug use to regular injecting: Retrospective survival analysis of injecting progression within a sample of people who inject drugs regularly.
  O'Keefe D, Horyniak D, Dietze P
  Drug Alcohol Depend. 2016 Jan; 158:177-180
• Age-related differences in patterns of criminal activity among a large sample of polydrug injectors in Australia.
  Horyniak D, Dietze P, Degenhardt. L, Agius P, Higgs P, Bruno R, Alati R, Burns L
  J Subst Abuse. 2016 Jan; 22(1):48-56
• One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort.
  Quinn B, Stoové MA, Dietze P
  J Subst Use. 2016 Jan; 21(3):279-286
• Influences on the drinking of heavier drinkers: Interactional realities in seeking to 'change drinking cultures'.
  Room R, Callinan S, Dietze P.
  Drug Alcohol Rev. 2016 Jan; 35(1):13-21

2015 (22)

• Mortality in the Melbourne injecting drug user cohort study (MIX).
  Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
  Harm Reduct J. 2015 Dec; 12(1):55
• Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
  Horyniak D, Agius PA, Degenhardt L, Reddel S, Higgs P, Aitken C, Stoové M, Dietze P
  Subst Use Misuse. 2015 Nov; 50(13):1650-1659
• Going tobacco free in Australian prisons – increasing tattooing harm?
  Treloar C, Baldry E, Higgs P, Dietze P, Stoové M, Lloyd A
  Int J Prisoner Health. 2015 Nov; 11(4):Viewpoint
• Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use.
  Kirwan A, Quinn B, Winter R, Kinner SA, Dietze P, Stoové M
  Harm Reduct J. 2015 Aug; 12(1):23
• Independent evaluation of the ‘Implementing Expanded Naloxone Availability in the ACT (I-ENAACT)’ Program, 2011-2014
  Olsen A, McDonald D, Lenton S, Dietze P
  Report prepared for ACT Health. 2015 Aug
• Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.
  Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P
  Drug Alcohol Depend. 2015 Jun; 154:208-213
• Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?
  Betts KS, McIlwraith F, Dietze P, Whittaker E, Burns L, Cogger S, Alati R
  Drug Alcohol Depend. 2015 Jun; 154:76-84
• The potential reach of opioid substitution settings to deliver HCV care to people who inject drugs in Australia.
  Butler K, Day C, Dietze P, Bruno R, Alati R, Burns L
  J Subst Abuse Treat. 2015 Jun; 58:90-94
• Alcohol Price Policies as an Instrument of Health Equity: Differential Effects of Tax and Minimum Price Measures.
  Callinan S, Room R, Dietze P
  Alcohol Alcohol. 2015 Jun; 50(6):629-30
• Temporal trends in cardiovascular demand in EMS: Weekday versus weekend differences.
  Cantwell K, Morgans A, Smith K, Livingston M, Dietze P
  Chronobiol Int. 2015 Jun; 32(6):731-738
• How patterns of injecting drug use evolve in a cohort of people who inject drugs.
  Scott N, Caulkins JP, Ritter A, Dietze P
  Trend Issues Crime Crim Justice. 2015 Jun; 502:1-20
• The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations.
  Larance B, Dietze P, Ali R, Lintzeris N, White N, Jenkinson R, Degenhardt L
  Drug Alcohol Rev. 2015 May; 34(6):603-610
• Understanding and describing Australian illicit drug markets: Drug price variations and associated changes in a cohort of people who inject drugs.
  Scott N, Caulkins JP, Dietze P, Ritter A
  National Drug Law Enforcement Research Fund. 2015 May; Monograph 58
• Patterns of drug preference and use among people who inject drugs in Melbourne, Australia
  Scott N, Caulkins JP, Ritter A, Dietze P
  Addict Res Theory. 2015 Apr; 23(6):459-468
• Multiply disadvantaged: Health and service utilisation factors faced by homeless injecting drug consumers in Australia.
  Whittaker E, Swift W, Roxburgh A, Dietze P, Cogger S, Bruno R, Sindicich N, Burns L
  Drug Alcohol Rev. 2015 Mar; 34(4):379-387
• Oral health-related quality of life among an Australian sample of people who inject drugs.
  Truong A, Higgs P, Cogger S, Jamieson L, Burns L, Dietze P
  J Public Health Dent. 2015 Mar; 75(3):218-24
• Time of Day and Day of Week Trends in EMS Demand.
  Cantwell K, Morgans A, Smith K, Livingston M, Spelman T, Dietze P
  Prehosp Emerg Care. 2015 Feb; 19(3):425-431
• 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
  Lim MS, Cogger S, Quinn B, Hellard ME, Dietze PM
  Aust N Z J Public Health. 2015 Jan; 39(2):194-195
• Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
  Lenton S, Dietze P, Olsen A, Wiggins N, McDonald D, Fowlie C
  Drug Alcohol Rev. 2015 Jan; 34(4):404-411
• High-Frequency Drug Purity and Price Series as Tools for Explaining Drug Trends and Harms in Victoria, Australia.
  Scott N, Caulkins JP, Ritter A, Quinn C, Dietze P
  Addiction. 2015 Jan; 110(1):120-128
• Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012.
  Nambiar D, Weir A, Aspinall EJ, Stoové M, Hutchinson S, Dietze P, Waugh L, Goldberg DJ
  Drug Alcohol Depend. 2015 Jan; 147:215-221
• How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.
  Horyniak D, Stoové M, Degenhardt L, Aitken C, Kerr T, Dietze P
  Int J Drug Policy. 2015 Jan; 26(1):43-50

2014 (21)

• Young risk takers: Alcohol, illicit drugs, and sexual practices among a sample of music festival attendees.
  Jenkinson R, Bowring A, Dietze P, Hellard M, Lim MSC
  J Sex Trans Dis. 2014 Dec; 2014:e357239
• Take-home emergency naloxone to prevent deaths from heroin overdose.
  Strang J, Bird SM, Dietze P, Gerra G, McLellan AT
  BMJ. 2014 Nov; 349:g6580
• Further research required to determine unique factors associated with dental care access among deprived populations.
  Truong A, Higgs P, Cogger S, Dietze P
  Public Health. 2014 Nov; 128(12):1131-1133
• Effect of Intubation for Gamma-hydroxybutyric Acid Overdose on Emergency Department Length of Stay and Hospital Admission.
  Dietze P, Horyniak D, Agius P, Munir V, Smit DV, Johnston J, Fry CL, Degenhardt L
  Acad Emerg Med. 2014 Nov; 21(11):1226-1231
• Driving under the influence among frequent ecstasy consumers in Australia: Trends over time and the role of risk perceptions.
  Matthews AJ, Bruno R, Dietze P, Butler K, Burns L
  Drug Alcohol Depend. 2014 Oct; 144:218-224
• Experiences of and Attitudes Toward Injecting Drug Use Among Marginalized African Migrant and Refugee Youth in Melbourne, Australia.
  Horyniak D, Higgs P, Cogger S, Dietze P, Bofu T, Seid G
  J Ethn Subst Abuse. 2014 Oct; 13(4):405-429
• A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs.
  Nambiar D, Stoové M, Dietze P
  BMC Health Serv Res. 2014 Jul; 14:308
• Understanding alcohol and other drug use during the event.
  Kuntsche E, Dietze P, Jenkinson R
  Drug Alcohol Rev. 2014 Jul; 33(4):335-337
• Victorian Trends in Ecstasy and Related Drug Markets 2012. Findings from the Ecstasy and related Drugs Reporting System (EDRS).
  Papanastasiou C, Dietze P, Lloyd B
  Australian Drug Trends Series No. 121. Sydney: NDARC, UNSW Australia. 2014 Jul
• Victorian Drug Trends 2013. Findings from the Illicit Drug Reporting System (IDRS).
  Cogger S, Dietze P, Lloyd B
  Australian Drug Trends Series No. 112. Sydney: NDARC, UNSW Australia. 2014 Jul
• 'Weekend on the town': Discrete sessions of drug use for a sample of young psychostimulant users.
  Jenkinson R, Jolley D, Dietze P
  Drug Alcohol Rev. 2014 Jun; 33(4):428-435
• Are users' most recent drug purchases representative?
  Bond B, Caulkins JP, Scott N, Kilmer B, Dietze P
  Drug Alcohol Depend. 2014 Jun; 142:133-138
• Heavy drinking occasions in Australia: Do context and beverage choice differ from low-risk drinking occasions?
  Callinan S, Livingston M, Dietze P, Room R
  Drug Alcohol Rev. 2014 Mar; 33(4):354-357
• The big night out: What happens on the most recent heavy drinking occasion among young Victorian risky drinkers?
  Dietze PM, Livingston M, Callinan S, Room R
  Drug Alcohol Rev. 2014 Mar; 33(4):346-353
• Improving the coding and classification of ambulance data through the application of International Classification of Disease 10th revision.
  Cantwell K, Morgans A, Smith K, Livingston M, Dietze P
  Aust Health Rev. 2014 Feb; 38(1):70-79
• Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs
  Reddel SE, Bruno R, Burns L, Kirwan A, Lokuge K, Dietze P
  Addiction. 2014 Feb; 109(2):295-302
• The diversion and injection of a buprenorphine-naloxone soluble film formulation.
  Larance B, Lintzeris N, Ali R, Dietze P, Mattick R, Jenkinson R, White N, Degenhardt L
  Drug Alcohol Depend. 2014 Jan; 136:21-27
• Substance misuse, mental health problems and recurrent child maltreatment.
  Laslett AM, Room R, Dietze P
  Adv Dual Diag. 2014 Jan; 7(1):15-23
• Self-reported recent testing and diagnosis for sexually transmitted infections among regular ecstasy users in Australia, 2011-2012.
  Nguyen PL, Bruno R, Alati R, Lenton S, Burns L, Dietze PM
  Drug Alcohol Rev. 2014 Jan; 33:211-214
• Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008-2010.
  Horyniak D, Degenhardt L, Smit DV, Munir V, Johnston J, Fry C, Dietze P
  Emerg Med J. 2014 Jan; 31(4):317-322
• Alcohol Consumption and Liver Disease in Australia: A Time Series Analysis of the Period 1935-2006.
  Jiang H, Livingston M, Room R, Dietze P, Norström T, Kerr WC
  Alcohol Alcohol. 2014 Jan; 49(3):363-368

2013 (23)

• Does free recall moderate the effect of mental context reinstatement instructions on children's cued recall?
  Dietze PM, Sharman, SJ, Powell MB, Thomson DM
  Psychol Crime Law. 2013 Nov; 19(10):881-891
• Who suggests drinking less? Demographic and national differences in informal social controls on drinking.
  Dietze P, Ferris J, Room R
  J Stud Alcohol Drugs. 2013 Nov; 74(6):859-866
• An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
  Quinn B, Stoové M, Papanastasiou C, Dietze P
  Int J Drug Policy. 2013 Jul; 24(6):619-23
• Commentary on Kerr et al. (2013): Advertising high-potency heroin.
  Dietze P
  Addiction. 2013 Jul; 108(7):1277-1278
• Victorian Drug Trends 2012. Findings from the Illicit Drug Reporting System (IDRS).
  Cogger S, Dietze P, Lloyd B
  Australian Drug Trends Series No. 94. Sydney: NDARC, UNSW Australia.. 2013 Jul
• Ecstasy and related Drugs Reporting System (EDRS) - Victorian Trends in Ecstasy and Related Drug Markets 2012.
  Nguyen P, Dietze P, Lloyd B
  Australian Drug Trends Series No. 103. Sydney: NDARC, UNSW Australia.. 2013 Jul
• Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results.
  Horyniak D, Higgs P, Jenkinson R, Degenhardt L, Stoové M, Kerr T, Hickman M, Aitken C, Dietze P
  Harm Reduct J. 2013 Jun; 10(1):11
• The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs.
  Horyniak D, Dietze P, Degenhardt L, Higgs P, McIlwraith F, Alati R, Bruno R, Lenton S, Burns L
  Drug Alcohol Depend. 2013 May; 132(3):541-6
• Epidemiology: Analysing patterns of drug use and harms.
  Dietze P, Stoove M, Laslett AM
  Book Chapter in "Drug Use in Australian Society" Ritter A, King T, Hamilton M (Eds). 2013 May; Chapter 4:67-98
• Comparing short versions of the AUDIT in a community-based survey of young people.
  Bowring AL, Gouillou M, Hellard M, Dietze P
  BMC Public Health. 2013 Apr; 13(1):301
• Factors associated with professional support access among a prospective cohort of methamphetamine users.
  Quinn B, Stoové M, Dietze P
  J Subst Abuse Treat. 2013 Mar; 45(2):235-241
• Surveying alcohol and other drug use through telephone sampling: a comparison of landline and mobile phone samples.
  Livingston M, Dietze P, Ferris J, Pennay D, Hayes L, Lenton S
  BMC Med Res Methodol. 2013 Mar; 13(1):41
• The place of volition in addiction: Differing approaches and their implications for policy and service provision.
  Karasaki M, Fraser S, Moore D, Dietze P
  Drug Alcohol Rev. 2013 Feb; 32(2):195-204
• The social location of heavy episodic alcohol consumption in the Victorian population.
  Matthews S, Dietze P, Room R, Chikritzhs T, Jolley D
  Drug Alcohol Rev. 2013 Feb; 32(2):157-61
• “Let’s Get Wasted!” and Other Apps: Characteristics, Acceptability, and Use of Alcohol-Related Smartphone Applications
  Weaver ER, Horyniak DR Jenkinson R, Dietze P, Lim MSC
  JMIR Mhealth Uhealth. 2013 Feb; 1(1):E9
• The relationship between alcohol use and injecting drug use: Impacts on health, crime and wellbeing.
  Dietze P, Jenkinson R, Aitken C, Stoové M, Jolley D, Hickman M, Kerr T
  Drug Alcohol Depend. 2013 Feb; 128(1-2):111-115
• Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs.
  O'Keefe D, Aitken C, Higgs P, Dietze P
  Drug Alcohol Rev. 2013 Feb; 32(2):208-210
• Methamphetamine use in Melbourne, Australia: baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence.
  Quinn B, Stoové M, Papanastasiou C, Dietze P
  J Subst Use. 2013 Jan; 18(5):349-362
• Ambulance demand: random events or predicable patterns?
  Cantwell K, Dietze P, Morgans AE, Smith K
  Emerg Med J. 2013 Jan; 30(11):883-887
• Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination?
  Winter RJ, Dietze PM, Gouillou M, Hellard ME, Robinson P, Aitken CK
  J Gastroenterol Hepatol. 2013 Jan; 28(2):314-322
• An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
  Bowring AL, Luhmann N, Pont S, Debaulieu C, Derozier S, Asouab F, Toufik A, van Gemert C, Dietze P, Stoové M
  Int J Drug Policy. 2013 Jan; 24(1):78-81
• A cross-sectional study of emergency department visits by people who inject drugs.
  Aitken C, Kerr T, Hickman M, Stoové M, Higgs P, Dietze P
  Emerg Med J. 2013 Jan; 30(5):421-422
• A response to: Self-reported and actual hepatitis C virus infection status.
  O'Keefe D, Aitken C, Higgs P, Dietze P
  Drug Alcohol Rev. 2013 Jan; 32(1):107

2012 (12)

• Injecting drug use and related health behaviours in a small case series of East African migrants in Melbourne.
  Horyniak D, Higgs P, Degenhardt L, Cogger S, Power R, Dietze P
  Aust N Z J Public Health. 2012 Dec; 36(6):586-587
• Prevalence and correlates of alcohol dependence in adult prisoners vary according to Indigenous status
  Kinner SA, Dietze P, Gouillou M, Alati R
  Aust NZ J Pub Health. 2012 Oct; 36(4):329-334
• Patients who attend the emergency department following medication overdose: Self-reported mental health history and intended outcomes of overdose.
  Buykx P, Ritter A, Loxley W, Dietze P
  Int J Mental Health Addict. 2012 Aug; 10(4): 501-511
• The use of alprazolam by people who inject drugs in Melbourne, Australia.
  Horyniak D, Reddel S, Quinn B, Dietze P
  Drug Alcohol Rev. 2012 Jun; 31(4):585-590
• The impact of khat use on East African communities in Melbourne: A preliminary investigation.
  Feigin A, Higgs P, Hellard M, Dietze P
  Drug Alcohol Rev. 2012 May; 31(3):288-293
• Alcohol's involvement in recurrent child abuse and neglect cases.
  Laslett AM, Room R, Dietze P, Ferris J.
  Addiction. 2012 Apr; 107(10):1786-1793
• Mobile safe injecting facilities in Barcelona and Berlin.
  Dietze P, Winter R, Pedrana A, Leicht A, Majó I Roca X, Brugal MT.
  Int J Drug Policy. 2012 Mar; 23(4):257-260
• Are drug detection dogs and mass-media campaigns likely to be effective policy responses to psychostimulant use and related harm? Results from an agent-based simulation model.
  Dray A, Perez P, Moore D, Dietze P, Bammer G, Jenkinson R, Siokou C, Green R, Hudson SL, Maher L
  Int J Drug Policy . 2012 Mar; 23(2):148-53.
• Know your limits: Awareness of the 2009 Australian alcohol guidelines among young people.
  Bowring AL, Gold J, Dietze P, Gouillou M, Van Gemert C, Hellard ME
  Drug Alcohol Rev. 2012 Mar; 31(2):213-223
• Social demography of alcohol-related harm to children in Australia.
  Laslett AM, Ferris J, Dietze P, Room R
  Addiction. 2012 Jan; 107(6):1082-1089
• SimAmph: an agent-based simulation model for exploring the use of psychostimulants and related harm amongst young Australians.
  Perez P, Dray A, Moore D, Dietze P, Bammer G, Jenkinson R, Siokou C, Green R, Hudson SL, Maher L
  Int J Drug Policy. 2012 Jan; 23(1):62-71
• Examination of the effect of mental reinstatement of context across developmental level, retention interval and type of mnemonic instruction
  Dietze PM, Powell MB, Thomson, DM
  Psychiat Psychol Law. 2012 Jan; 19(1):89-103

2011 (6)

• Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing.
  Larance B, Degenhardt L, Lintzeris N, Bell J, Winstock A, Dietze P, Mattick R, Ali R, Horyniak D
  Drug Alcohol Dependence:. 2011 Nov; 118(2-3):265-273
• Heroin and other opioids
  Dietze P, Degenhardt L, Kinner S, Hellard M, King T
  Prevention Research Quarterly. 2011 Sep; 16:1-12
• Alcohol-related negative consequences among drinkers around the world.
  Graham K, Bernards S, Knibbe R, Kairouz S, Kuntche S, Wilsnack SC, Greenfield TK, Dietze P, Obot I, Gmel G
  Addiction. 2011 Aug; 106(8):1391-1405
• The Australian national binge drinking campaign: campaign recognition among young people at a music festival who report risky drinking.
  van Gemert C, Dietze P, Gold J, Sacks-Davis R, Stoové M, Vally H, Hellard M
  BMC Public Health. 2011 Jun; 11:482
• The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
  Horyniak D, Dietze P, Larance B, Winstock A, Degenhardt L
  Int J Drug Policy. 2011 Mar; 22(2):167-171
• The adverse consequences of drinking in a sample of Australian adults.
  Dietze P, Room R, Jolley D, Matthews S, Chikritzhs T
  J Substance Use. 2011 Feb; 16(2):116-126

2010 (9)

• The self-reported personal wellbeing of a sample of Australian injecting drug users.
  Dietze P, Stoové M, Miller P, Kinner S, Bruno R, Alati R, Burns L
  Addiction. 2010 Dec; 105(12):2141-2148
• Medications used in overdose and how they are acquired - an investigation of cases attending an inner Melbourne emergency department.
  Buykx P, Loxley W, Dietze P, Ritter A
  Aust N Z J Public Health. 2010 Aug; 34(4):401-404
• The relationship between alcohol supply source and young people's risky drinking and alcohol-related problem behaviours in Victoria, Australia.
  Dietze PM, Livingston M
  Aust N Z J Public Health. 2010 Aug; 34(4):364-367
• Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases?
  Buykx P, Dietze P, Ritter A, Loxley W
  Emerg Med J. 2010 Jul; 27(7):499-503
• Further research required to determine link between khat consumption and driver impairment.
  Feigin A, Higgs P, Hellard M, Dietze P
  Bull World Health Organ. 2010 Jun; 88(6):480
• The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand.
  Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR
  Accid Anal Prev. 2010 May; 42(3):859-866
• Mental reinstatement of context with child witnesses: does it matter whether context is reinstated 'out loud'?
  Dietze PM, Powell MB, Thomson DM
  Psychology Crime and Law. 2010 Jan; 16:439-448
• An evaluation of a heroin overdose prevention and education campaign.
  Horyniak D, Higgs P, Lewis J, Winter R, Dietze P, Aitken C
  Drug Alcohol Rev. 2010 Jan; 29(1):5-11
• The characteristics of acute non-fatal medication-related events attended by ambulance services in the Melbourne Metropolitan Area 1998-2002.
  Hutton J, Dent A, Buykx P, Burgess S, Flander L, Dietze P
  Drug Alcohol Rev. 2010 Jan; 29(1):53-58

2009 (8)

• Extending drug ethno-epidemiology using agent-based modelling.
  David Moore, Anne Dray, Rachael Green, Susan L Hudson, Rebecca Jenkinson, Christine Siokou, Pascal Perez, Gabriele Bammer, Lisa Maher, Paul Dietze
  Addiction. 2009 Dec; 104(12):1991-1997
• Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
  Kerr D, Kelly AM, Dietze P, Jolley D, Barger B
  Addiction. 2009 Dec; 104(12):2067-2074
• Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia.
  Lenton SR, Dietze PM, Degenhardt L, Darke S, Butler TG
  Drug Alcohol Rev. 2009 Nov; 28(6):583-585
• Naloxone for administration by peers in cases of heroin overdose.
  Lenton SR, Dietze PM, Degenhardt L, Darke S, Butler TG
  Med J Aust. 2009 Oct; 191(8):469
• Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
  Stoové MA, Dietze PM, Jolley D
  Drug Alcohol Rev. 2009 Jul; 28(4):347-352
• Improved response by peers after witnessed heroin overdose in Melbourne.
  Kerr D, Dietze P, Kelly AM, Jolley D.
  Drug Alcohol Rev. 2009 May; 28(3):327-330
• The "alcopops" tax: heading in the right direction.
  Chikritzhs TN, Dietze PM, Allsop SJ, Daube MM, Hall WD, Kypri K
  Med J Aust. 2009 Mar; 190(6):294-295
• Income inequality and alcohol attributable harm in Australia.
  Dietze PM, Jolley DJ, Chikritzhs TN, Clemens S, Catalano P, Stockwell T
  BMC Public Health. 2009 Feb; 9:70

2008 (10)

• Individual and community correlates of young people's high-risk drinking in Victoria, Australia.
  Livingston M, Laslett AM, Dietze P
  Drug Alcohol Depend. 2008 Dec; 98(3):241-248
• Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
  Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D
  J Subst Abuse Treat. 2008 Dec; 35(4):457-461
• Drinking by professional Australian Football League (AFL) players: prevalence and correlates of risk.
  Dietze PM, Fitzgerald JL, Jenkinson RA
  Med J Aust. 2008 Nov; 189(9):479-483
• The oral health of street-recruited injecting drug users: prevalence and correlates of problems.
  Laslett AM, Dietze P, Dwyer R
  Addiction. 2008 Nov; 103(11):1821-1825
• Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).
  Stoové MA, Dietze PM, Aitken CK, Jolley D
  Drug Alcohol Depend. 2008 Aug; 96(3):281-285
• What more can we learn from the heroin drought?
  Dietze P
  Int J Drug Policy. 2008 Aug; 19(4):270-272
• Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
  Dietze PM, Cvetkovski S, Barratt MJ, Clemens S
  Med J Aust. 2008 Jun; 188(12):709-711
• Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
  Kerr D, Dietze P, Kelly AM, Jolley D
  J Urban Health. 2008 May; 85(3):352-360
• Intranasal naloxone for the treatment of suspected heroin overdose.
  Kerr D, Dietze P, Kelly AM
  Addiction. 2008 Mar; 103(3):379-386
• The incidence and characteristics of volatile substance use related ambulance attendances in metropolitan Melbourne, Australia.
  Stefan Cvetkovski, Paul Dietze
  Soc Sci Med. 2008 Feb; 66(3):776-783

2007 (4)

• Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.
  James Shearer, Jennifer Johnston, Craig L Fry, Sharlene Kaye, Paul Dillon, Paul Dietze, Linette Collins
  Drug Alcohol Rev. 2007 Sep; 26(5):537-543
• Dynamic compartmental model of trends in Australian drug use.
  Jonathan P Caulkins, Paul Dietze, Alison Ritter
  Health Care Manag Sci. 2007 Jun; 10(2):151-162
• Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
  Suzanne Nielsen, Paul Dietze, Nicole Lee, Adrian Dunlop, David Taylor
  Addiction. 2007 Apr; 102(4):616-622
• Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.
  Suzanne Nielsen, Paul Dietze, Adrian Dunlop, Peter Muhleisen, Nicole Lee, David Taylor
  Drug Alcohol Rev. 2007 Mar; 26(2):143-151

2006 (2)

• When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors.
  Paul Dietze, Damien Jolley, Craig L Fry, Gabriele Bammer, David Moore
  Drug Alcohol Depend. 2006 Oct; 84(3):223-230
• Effect of opioid substitution therapy on alcohol metabolism.
  Nicolas C Clark, Paul Dietze, Michael G Lenne, Jennifer R Redman
  J Subst Abuse Treat. 2006 Apr; 30(3):191-196

2005 (6)

• Effects of a sustained heroin shortage in three Australian States.
  Louisa Degenhardt, Carolyn Day, Paul Dietze, Sophie Pointer, Elizabeth Conroy, Linette Collins, Wayne Hall
  Addiction. 2005 Jul; 100(7):908-920
• The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
  Kate Cantwell, Paul Dietze, Louisa Flander
  Resuscitation. 2005 Jun; 65(3):315-319
• Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose.
  Paul Dietze, Damien Jolley, Craig Fry, Gabriele Bammer
  Addiction. 2005 May; 100(5):636-642
• Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice.
  David Moore, Paul Dietze
  Drug Alcohol Rev. 2005 May; 24(3):275-284
• Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey.
  Carolyn A Day, Joanne Ross, Paul Dietze, Kate Dolan
  Harm Reduct J. 2005 Feb; 2(1):2
• Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
  Anne-Maree Kelly, Debra Kerr, Paul Dietze, Ian Patrick, Tony Walker, Zeff Koutsogiannis
  Med J Aust. 2005 Jan; 182(1):24-27

2004 (1)

• Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.
  Paul Dietze, Damien Jolley, Stefan Cvetkovski, Kate Cantwell, Ian Jacobs, Devon Indig
  Aust N Z J Public Health. 2004 Dec; 28(6):569-575

2003 (3)

• The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving.
  Michael G Lenne, Paul Dietze, Greg R Rumbold, Jennifer R Redman, Thomas J Triggs
  Drug Alcohol Depend. 2003 Dec; 72(3):271-278
• Intentional overdose among heroin overdose survivors.
  Penny Heale, Paul Dietze, Craig Fry
  J Urban Health. 2003 Jun; 80(2):230-237
• Patterns and characteristics of ambulance attendance at heroin overdose at a local-area level in Melbourne, Australia: implications for service provision.
  Paul Dietze, Damien Jolley, Stefan Cvetkovski
  J Urban Health. 2003 Jun; 80(2):248-260

2002 (5)

• Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles?
  Paul Dietze, John Fitzgerald
  Drug Alcohol Rev. 2002 Sep; 21(3):295-303
• Bystander resuscitation attempts at heroin overdose: does it improve outcomes?
  Paul Dietze, Kate Cantwell, Stephen Burgess
  Drug Alcohol Depend. 2002 Jul; 67(2):213-218
• Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose.
  Paul Dietze, Craig Fry, Sandra Sunjic, Gabriele Bammer, Deborah Zador, Damien Jolley, Greg Rumbold
  Drug Alcohol Depend. 2002 Jun; 67(1):99-103
• Estimated alcohol-caused deaths in Australia, 1990-97.
  Penny Heale, Tanya Chikritzhs, Helen Jonas, Timothy Stockwell, Paul Dietze
  Drug Alcohol Rev. 2002 Jun; 21(2):121-129
• How much alcohol is drunk in Australia in excess of the new Australian alcohol guidelines?
  Tim R Stockwell, Penny Heale, Tanya N Chikritzhs, Paul Dietze, Paul Catalano
  Med J Aust. 2002 Jan; 176(2):91-92

2001 (1)

• Mortality and life-years lost due to alcohol: a comparison of acute and chronic causes.
  T N Chikritzhs, H A Jonas, T R Stockwell, P F Heale, P M Dietze
  Med J Aust. 2001 Mar; 174(6):281-284

2000 (1)

• Naloxone distribution: remembering hepatitis C transmission as an issue.
  Fry C, Dietze P, Crofts N
  Addiction. 2000 Dec; 95(12):1865-1866

1999 (1)

• Associations between alcohol related hospital admissions and alcohol consumption in Victoria: influence of socio-demographic factors.
  H Jonas, P Dietze, G Rumbold, K Hanlin, S Cvetkovski, A M Laslett
  Aust N Z J Public Health. 1999 Jun; 23(3):272-279

1922 (1)

• Conflict and communication: managing the multiple affordances of take-home naloxone administration events in Australia.
  Farrugia A, Neale J, Dwyer R, Fomiatti R, Fraser S, Strang J, Dietze P
  Addict Theory Res. 1922 Jan; 28(1):29-37

News Articles (61)

2020 (11)

• 2020 in Review: January to June
• NHMRC Ideas Grants for Burnet research
• IMPACT special edition now online!
• New collaboration with NDRI
• Focus on follow-up care to real-time prescription monitoring
• Safe injecting facility recommendations endorsed
• Focus on research into COVID-19 impact on drug use
• Insights into COVID-19 impact on drug market
• Burnet to advise on ACT safe injecting facility
• New study explores COVID impact on drug use
• Focus on barriers to naloxone access

2019 (6)

• Research needed on correct nasal naloxone dosage
• Nasal naloxone wins PBS approval
• Focus on naloxone to prevent overdose
• Victorian budget investments welcomed
• Burnet’s innovative research receives fast-track funding
• Federal funding for naloxone research

2018 (6)

• NHMRC grants for Burnet research
• Preventing and responding to opioid overdose in Victoria
• Bumper turnout for Student Night
• New medication for 'ice' on trial
• Evaluation needed for safe injecting facility
• Vale Jenny Kelsall

2017 (10)

• Burnet excels in NHMRC funding
• APSAD Oration focus on opioid overdose
• Burnet welcomes trial of safe injecting facility
• Saving Lives and SIF: Aaron’s story
• Burnet researchers share in NHMRC grants
• Older drug injectors require attention too
• Random drug tests no deterrent to drug-users' driving
• The case for new hepatitis C treatments
• Support for Coroner's findings on 'essential' injecting facility
• Support for trial of medically supervised injection facility

2016 (6)

• NHMRC grants for Burnet researchers
• CREIDU focus on take-home naloxone
• NHMRC grant to assist hepatitis C research
• Harmful drinking gets personal
• Study queries CCTV as drug deal deterrent
• Young Australians turning away from alcohol

2015 (8)

• Naloxone access welcomed
• Burnet's NHMRC success rate among Australia's best
• Explainer: what is naloxone and how can it help save drug users who overdose?
• CREIDU Colloquium 2015: Five minute talk can save a life
• Governor visits Burnet
• Meth fight requires new focus
• Report supports take-home naloxone
• Higher purity causing 'ice' harm

2014 (3)

• 2014 In Review: July - December
• CREIDU support for WHO Opioid Overdose Guidelines
• ‘Ice Epidemic?’ How increased purity of crystal meth explains Victoria’s rising methamphetamine related harms

2013 (5)

• 2013: Year in Review
• Outstanding Burnet researcher presents Fenner Lecture
• CREIDU Colloquium: Take-home naloxone could save lives
• Report reveals adverse impact of public injecting in Nth Richmond
• Reaching Out: Working with Melbourne’s most vulnerable

2012 (2)

• Suboxone® in Australia: focus of CREIDU Colloquium
• Supervised injecting facilities: Do they work?

2011 (4)

• Australian-first overdose management program launched
• Concern over methadone doctor shortage
• Global study: Australian women suffering consequences of drinking alcohol
• Alcohol and drug use research boosted by ARC Future Fellowship